Correlation Between Chengdu Kanghua and Innovative Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Chengdu Kanghua and Innovative Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chengdu Kanghua and Innovative Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chengdu Kanghua Biological and Innovative Medical Management, you can compare the effects of market volatilities on Chengdu Kanghua and Innovative Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chengdu Kanghua with a short position of Innovative Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chengdu Kanghua and Innovative Medical.

Diversification Opportunities for Chengdu Kanghua and Innovative Medical

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Chengdu and Innovative is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Chengdu Kanghua Biological and Innovative Medical Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovative Medical and Chengdu Kanghua is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chengdu Kanghua Biological are associated (or correlated) with Innovative Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovative Medical has no effect on the direction of Chengdu Kanghua i.e., Chengdu Kanghua and Innovative Medical go up and down completely randomly.

Pair Corralation between Chengdu Kanghua and Innovative Medical

Assuming the 90 days trading horizon Chengdu Kanghua Biological is expected to under-perform the Innovative Medical. But the stock apears to be less risky and, when comparing its historical volatility, Chengdu Kanghua Biological is 1.72 times less risky than Innovative Medical. The stock trades about -0.06 of its potential returns per unit of risk. The Innovative Medical Management is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  864.00  in Innovative Medical Management on September 1, 2024 and sell it today you would earn a total of  25.00  from holding Innovative Medical Management or generate 2.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Chengdu Kanghua Biological  vs.  Innovative Medical Management

 Performance 
       Timeline  
Chengdu Kanghua Biol 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Chengdu Kanghua Biological are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Chengdu Kanghua sustained solid returns over the last few months and may actually be approaching a breakup point.
Innovative Medical 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Innovative Medical Management are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Innovative Medical sustained solid returns over the last few months and may actually be approaching a breakup point.

Chengdu Kanghua and Innovative Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Chengdu Kanghua and Innovative Medical

The main advantage of trading using opposite Chengdu Kanghua and Innovative Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chengdu Kanghua position performs unexpectedly, Innovative Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovative Medical will offset losses from the drop in Innovative Medical's long position.
The idea behind Chengdu Kanghua Biological and Innovative Medical Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets